Zealand Pharma issues almost USD 40m in shares
The firm’s issuance and private placement represent 6.6% of its currently registered share capital, and will bring in an expected total of DKK 275m (USD 39.4m).
by marketwire, translated by daniel pedersen
Biotech firm Zealand Pharma has announced a directed issuance of 2.89 million new shares and a private placement, corresponding to a total 6.6% of the firm’s share capital.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma CEO believes in firm's obesity efforts
For subscribers
Zealand Pharma stock soars after selling insulin pump
For subscribers
.jpg&w=384&q=75)
